Pharmaceutical companies have long been driven by global demand and the potential for the highest profits, often leaving patients with rare diseases behind.
Great Ormond Street Hospital is attempting to obtain the license for a rare gene therapy on a non-profit basis, setting a precedent for NHS trusts to market drugs for treatments pharmaceutical companies might overlook.
#healthcare-providers #rare-diseases #life-saving-treatments #pharmaceutical-companies #access-to-treatment
[
add
]
[
|
|
...
]